JOHN SCHMIDT: Open Payments
NPI 1326721903 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$740 in 17 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $740
Food & beverage: $647Education: $93
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $380 |
| Regeneron Healthcare Solutions, Inc. | 1 | $98 |
| Janssen Biotech, Inc. | 1 | $93 |
| Daiichi Sankyo Inc. | 3 | $56 |
| Janssen Scientific Affairs, LLC | 1 | $36 |
| Astellas Pharma US Inc | 1 | $31 |
| Ipsen Biopharmaceuticals, Inc | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $21 |
Products named: RYBREVANT, LIBTAYO, TAGRISSO, Vyloy, Onivyde, Enhertu, KEYTRUDA, IMFINZI.
Industry payments across NC — which companies pay providers there.
